- Home
- SHBI vs SVRA Comparison
SHBI vs SVRA Comparison
Compare SHBI & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHBI
- SVRA
- Stock Information
- Founded
- SHBI 1876
- SVRA 2007
- Country
- SHBI United States
- SVRA United States
- Employees
- SHBI N/A
- SVRA N/A
- Industry
- SHBI Major Banks
- SVRA Biotechnology: Pharmaceutical Preparations
- Sector
- SHBI Finance
- SVRA Health Care
- Exchange
- SHBI Nasdaq
- SVRA Nasdaq
- Market Cap
- SHBI 548.4M
- SVRA 527.2M
- IPO Year
- SHBI N/A
- SVRA N/A
- Fundamental
- Price
- SHBI $15.67
- SVRA $4.30
- Analyst Decision
- SHBI Buy
- SVRA Buy
- Analyst Count
- SHBI 1
- SVRA 8
- Target Price
- SHBI $20.00
- SVRA $6.88
- AVG Volume (30 Days)
- SHBI 137.4K
- SVRA 1.6M
- Earning Date
- SHBI 10-23-2025
- SVRA 11-13-2025
- Dividend Yield
- SHBI 3.07%
- SVRA N/A
- EPS Growth
- SHBI 38.19
- SVRA N/A
- EPS
- SHBI 1.71
- SVRA N/A
- Revenue
- SHBI $212,493,000.00
- SVRA N/A
- Revenue This Year
- SHBI N/A
- SVRA N/A
- Revenue Next Year
- SHBI $6.89
- SVRA N/A
- P/E Ratio
- SHBI $9.15
- SVRA N/A
- Revenue Growth
- SHBI 10.07
- SVRA N/A
- 52 Week Low
- SHBI $11.47
- SVRA $1.89
- 52 Week High
- SHBI $17.67
- SVRA $4.51
- Technical
- Relative Strength Index (RSI)
- SHBI 44.80
- SVRA 67.57
- Support Level
- SHBI $15.45
- SVRA $4.14
- Resistance Level
- SHBI $16.10
- SVRA $4.51
- Average True Range (ATR)
- SHBI 0.49
- SVRA 0.25
- MACD
- SHBI 0.01
- SVRA 0.02
- Stochastic Oscillator
- SHBI 45.26
- SVRA 81.33
About SHBI Shore Bancshares Inc
Shore Bancshares Inc is a financial holding company. It offers personalized banking, insurance, and investment services to families and businesses in the Mid-Atlantic region. It operates in one business segment- banking. The company's primary source of revenue is derived from interest earned on commercial, residential mortgage and other loans, and fees charged in connection with lending and other banking services located in Maryland, Delaware and Virginia.
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.